NCT04843527View on ClinicalTrials.gov

Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes

NAActive, not recruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

April 2, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Diabetes Mellitus, Type 2
Interventions
DEVICE

FreeStyle Libre System

FreeStyle Libre Flash Glucose Monitoring System

DEVICE

FreeStyle Libre System plus food app

FreeStyle Libre Flash Glucose Monitoring System and Smartphone Food Logging application

Trial Locations (4)

15213

UMPC, Pittsburgh

48202

Henry Ford Health System, Detroit

55416

HealthPartners Institute dba International Diabetes Center, Minneapolis

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Abbott Diabetes Care

INDUSTRY

NCT04843527 - Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes | Biotech Hunter | Biotech Hunter